DE60326781D1 - Lichtaktivierte Gentransduktion unter Verwendung von ultraviolettem Licht zur zellengerichteten Zuführung von Genen - Google Patents

Lichtaktivierte Gentransduktion unter Verwendung von ultraviolettem Licht zur zellengerichteten Zuführung von Genen

Info

Publication number
DE60326781D1
DE60326781D1 DE60326781T DE60326781T DE60326781D1 DE 60326781 D1 DE60326781 D1 DE 60326781D1 DE 60326781 T DE60326781 T DE 60326781T DE 60326781 T DE60326781 T DE 60326781T DE 60326781 D1 DE60326781 D1 DE 60326781D1
Authority
DE
Germany
Prior art keywords
cell
light
ultraviolet light
vector
genes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60326781T
Other languages
English (en)
Inventor
Edward M Schwarz
Thomas Foster
Regis J O'keefe
Jarod C Finlay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Rochester
Original Assignee
University of Rochester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Rochester filed Critical University of Rochester
Application granted granted Critical
Publication of DE60326781D1 publication Critical patent/DE60326781D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0083—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the administration regime
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE60326781T 2002-01-31 2003-01-31 Lichtaktivierte Gentransduktion unter Verwendung von ultraviolettem Licht zur zellengerichteten Zuführung von Genen Expired - Lifetime DE60326781D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35390702P 2002-01-31 2002-01-31
US35384202P 2002-01-31 2002-01-31

Publications (1)

Publication Number Publication Date
DE60326781D1 true DE60326781D1 (de) 2009-04-30

Family

ID=27669127

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60310525T Expired - Lifetime DE60310525T2 (de) 2002-01-31 2003-01-31 Ultraviolette licht zur lichtaktivierten gentransduktion bei der genzuführung
DE60326781T Expired - Lifetime DE60326781D1 (de) 2002-01-31 2003-01-31 Lichtaktivierte Gentransduktion unter Verwendung von ultraviolettem Licht zur zellengerichteten Zuführung von Genen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE60310525T Expired - Lifetime DE60310525T2 (de) 2002-01-31 2003-01-31 Ultraviolette licht zur lichtaktivierten gentransduktion bei der genzuführung

Country Status (7)

Country Link
US (2) US7524327B2 (de)
EP (3) EP1472348B1 (de)
AT (2) ATE348884T1 (de)
AU (1) AU2003210820B2 (de)
CA (1) CA2474485A1 (de)
DE (2) DE60310525T2 (de)
WO (1) WO2003064680A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE348884T1 (de) * 2002-01-31 2007-01-15 Univ Rochester Ultraviolette licht zur lichtaktivierten gentransduktion bei der genzuführung
US7704272B2 (en) * 2002-01-31 2010-04-27 University Of Rochester Method for introducing an ultraviolet light activated viral vector into the spinal column
CA2514643A1 (en) * 2003-01-31 2004-08-19 University Of Rochester Light probe for ultraviolet light activated gene transduction
WO2006024038A2 (en) * 2004-08-27 2006-03-02 Codman & Shurtleff Light-based implant for treating alzheimer’s disease
US8697139B2 (en) 2004-09-21 2014-04-15 Frank M. Phillips Method of intervertebral disc treatment using articular chondrocyte cells
US7288108B2 (en) 2005-03-14 2007-10-30 Codman & Shurtleff, Inc. Red light implant for treating Parkinson's disease
USRE47266E1 (en) * 2005-03-14 2019-03-05 DePuy Synthes Products, Inc. Light-based implants for treating Alzheimer's disease
US8463439B2 (en) 2009-03-31 2013-06-11 Intuitive Surgical Operations, Inc. Optic fiber connection for a force sensing instrument
US7351253B2 (en) 2005-06-16 2008-04-01 Codman & Shurtleff, Inc. Intranasal red light probe for treating Alzheimer's disease
US8167920B2 (en) * 2005-10-31 2012-05-01 Codman & Shurtleff, Inc. Intranasal delivery of compounds that reduce intrancranial pressure
JP4761224B2 (ja) * 2006-10-12 2011-08-31 富士電機デバイステクノロジー株式会社 垂直磁気記録媒体
US9320914B2 (en) 2008-03-03 2016-04-26 DePuy Synthes Products, Inc. Endoscopic delivery of red/NIR light to the subventricular zone

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT395321B (de) * 1983-07-05 1992-11-25 Ebner Ind Ofenbau Verfahren zum abkuehlen von chargen in diskontinuierlich arbeitenden industrieoefen, insbesondere von stahldraht- oder - bandbunden in haubengluehoefen
CA1245726A (en) 1984-01-19 1988-11-29 Francis A. L'esperance Laser incisional device
US4671273A (en) 1984-03-19 1987-06-09 Lindsey Ernest J Laser hand piece, for use in opthalmic, plastic, and ear, nose, and throat surgery
DE3415293A1 (de) 1984-04-24 1985-11-14 Osada Electric Co. Ltd., Tokio/Tokyo Laser-handgeraet
US5188632A (en) * 1984-12-07 1993-02-23 Advanced Interventional Systems, Inc. Guidance and delivery system for high-energy pulsed laser light
US4846172A (en) * 1987-05-26 1989-07-11 Berlin Michael S Laser-delivery eye-treatment method
WO1989003202A2 (en) 1987-10-14 1989-04-20 Schneider Richard T Method and apparatus for laser emulsification
US5084043A (en) * 1990-01-12 1992-01-28 Laserscope Method for performing a percutaneous diskectomy using a laser
US5242439A (en) * 1990-01-12 1993-09-07 Laserscope Means for inserting instrumentation for a percutaneous diskectomy using a laser
US5201729A (en) * 1990-01-12 1993-04-13 Laserscope Method for performing percutaneous diskectomy using a laser
DE4219626A1 (de) 1992-06-16 1993-12-23 Wehling Peter Priv Doz Dr Med Methode zur Einschleusung therapeutisch relevanter Gene in Körperzellen
US5340734A (en) * 1992-11-25 1994-08-23 Biosource Genetics Corporation Method for making stable, extracellular tyrosinase and synthesis of polyphenolic polymers therefrom
AU692434B2 (en) 1993-01-21 1998-06-11 President And Fellows Of Harvard College Methods and diagnostic kits utilizing mammalian stress promoters to determine toxicity of a compound
DE9317847U1 (de) 1993-10-29 1994-01-20 Witwity Taufik Dr Kanüle
US5604090A (en) * 1994-06-06 1997-02-18 Fred Hutchinson Cancer Research Center Method for increasing transduction of cells by adeno-associated virus vectors
IL115851A0 (en) * 1995-11-02 1996-01-31 Riklis Emanual Cosmetic compositions
US5883740A (en) * 1995-12-14 1999-03-16 Chubb; Charles R. Skin light exposure control methods
US5843459A (en) * 1996-01-19 1998-12-01 Human Gene Therapy Research Institute Differential inactivation of nucleic acids by chemical modification
US6300127B1 (en) * 1997-07-30 2001-10-09 Emory University Bone mineralization proteins, DNA, vectors, expression systems
DE29716011U1 (de) * 1997-09-06 1997-10-30 Reitenbach Paul Gerät zur ultravioletten intravenösen Bestrahlung des Eigenblutes mit fieberoptischer Lichtsonde
WO1999047177A1 (en) 1998-03-18 1999-09-23 The University Of Virginia Patent Foundation Gene therapy vector with osteocalcin promoter and genes for bone morphogenic proteins or growth factors
US6593084B2 (en) * 1998-10-13 2003-07-15 Robert E. Bird Carcinogen assay
US6254547B1 (en) * 1999-11-08 2001-07-03 Michael Phillips Breath methylated alkane contour: a new marker of oxidative stress and disease
AUPQ306999A0 (en) * 1999-09-24 1999-10-21 Canon Kabushiki Kaisha Intercom system
EP1130086A1 (de) * 2000-02-18 2001-09-05 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Genetische manipulierte Keratinozyten und deren Verwendung zur Prüfung der Toxizität
AU2002241628A1 (en) * 2000-12-15 2002-06-24 Mitokor Cobalt-porphyrin complexes and use thereof as an anti-obesity agent
US20030023284A1 (en) * 2001-02-20 2003-01-30 Vladimir Gartstein Method and apparatus for the in-vivo treatment of pathogens
ES2276728T3 (es) * 2001-02-23 2007-07-01 Chemisches Laboratorium Dr. Kurt Richter Gmbh Composicion de uso topico.
US7704272B2 (en) * 2002-01-31 2010-04-27 University Of Rochester Method for introducing an ultraviolet light activated viral vector into the spinal column
ATE348884T1 (de) * 2002-01-31 2007-01-15 Univ Rochester Ultraviolette licht zur lichtaktivierten gentransduktion bei der genzuführung
CA2514643A1 (en) * 2003-01-31 2004-08-19 University Of Rochester Light probe for ultraviolet light activated gene transduction

Also Published As

Publication number Publication date
DE60310525T2 (de) 2007-10-04
US7524327B2 (en) 2009-04-28
EP1472348A4 (de) 2005-04-13
WO2003064680A2 (en) 2003-08-07
AU2003210820B2 (en) 2007-12-20
EP1472348B1 (de) 2006-12-20
EP1867715B1 (de) 2009-03-18
US20030236394A1 (en) 2003-12-25
EP1939285A1 (de) 2008-07-02
CA2474485A1 (en) 2003-08-07
EP1472348A2 (de) 2004-11-03
US20090093867A1 (en) 2009-04-09
ATE426020T1 (de) 2009-04-15
EP1867715A1 (de) 2007-12-19
ATE348884T1 (de) 2007-01-15
WO2003064680A3 (en) 2004-07-22
DE60310525D1 (de) 2007-02-01

Similar Documents

Publication Publication Date Title
DE60326781D1 (de) Lichtaktivierte Gentransduktion unter Verwendung von ultraviolettem Licht zur zellengerichteten Zuführung von Genen
DE69535563D1 (de) Transgene pflanzen, die dna-konstrukteexpremieren, die mehrere virusresistenz-verleihende gene enthalten
ATE470704T1 (de) Rekombinantes sendai-virus
ATE419383T1 (de) Charakterisierung von genfunktion an hand doppelsträngiger-rns inhibition
BRPI0518756B8 (pt) processo para preparar um hidrogel adesivo sensível à pressão
EA200701450A1 (ru) РНКi МОДУЛЯЦИЯ RSV И ЕЁ ТЕРАПЕВТИЧЕСКОЕ ПРИМЕНЕНИЕ
AU6872000A (en) Paramyxoviruses having modified transcription initiation sequence
DE69634904D1 (de) Negativstrand rna virus mit selbständiger replikationsaktivität
PL331005A1 (en) Regulating dna of hamster's ef-1alpha transcription
DK0625048T3 (da) Syntese af humane procollagener og collagener i rekombinant DNA-systemer
MXPA05012926A (es) Composicion de revestimiento curable con radiacion ultravioleta.
MXPA05011847A (es) Revestimientos fotocurados y estabilizados.
ATE397655T1 (de) Verfahren zur erhöhung der leistungsfähigkeit der rekombinanten aav produktion
Anderson et al. Natural variation in stochastic photoreceptor specification and color preference in Drosophila
DE60225312D1 (de) Samenspezifische 7s-alpha-promoter zur expression von genen in pflanzen
ATE391186T1 (de) Gezielte verabreichung von kuenstlichen genen
ATE423177T1 (de) Photoinitiatoren zur verwendung in tiefdruckfarben
HUP0102911A2 (hu) Indukálható promóterek
ATE456662T1 (de) Genetisch veränderte dendritische zellen, die mit adeno-assoziiertem virus transduziert wurden, verfahren zur herstellung dieser zellen und ihre verwendungen
WO2002066636A3 (en) T cell receptor variants expressed in mesenchymal cells and uses thereof
DE60222100D1 (de) "schleifsteinkorn, schleifstein und verfahren zu ihrer herstellung sowie verfahren zur herstellung optischer elemente unter verwendung des schleifsteins und verfahren zur herstellung von projektionsausrichtern"
DE69515645T2 (de) Cd69 - transkriptionsregulierende elemente
ATE439143T1 (de) Hm1.24 verwertende krebsvakzine
SE9502259L (sv) Oligonukleotider för att inhibera expression av isoprenylproteintransferas
BR0316224A (pt) Sequência de dna da região genÈmica tcd de photorhabdus luminescens

Legal Events

Date Code Title Description
8364 No opposition during term of opposition